Pfizer, Siemens Partner in Companion Diagnostics

News
Article

Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.

Siemens has entered into an agreement with Pfizer to design, develop, and commercialize diagnostic tests for therapeutic products across Pfizer's pipeline. Under the agreement, Siemens will be one of Pfizer's collaboration partners to develop and provide in vitro diagnostic tests for use in clinical studies.

The partnership will help Siemens' in providing clinical diagnostic solutions for hospital and reference laboratories, specialty laboratories, and point-of-care settings (including clinics and physician offices) to help enable diagnostics development.

Source: Siemens

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Related Content